Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome

Clinical Lymphoma, Myeloma and Leukemia

Volumn 16, Issue 4, 2016, Pages 230-236

  Johnson, Benny ^a   Giri, Smith ^a   Nunnery, Sara E ^a   Wiedower, Eric ^a   Jamy, Omer ^a   Yaghmour, George ^a   Chandler, Jason C ^a   Martin, Mike G ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Autoimmune disease; Charlson comorbidity index; Malignancy; Organ dysfunction; Secondary hemophagocytic syndrome

Indexed keywords

ANTINEOPLASTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMORBIDITY ASSESSMENT; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEMIPLEGIA; HEMOPHAGOCYTIC SYNDROME; HISTOPLASMOSIS; HOSPITALIZATION COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-9-CM; LENGTH OF STAY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; RHEUMATOID ARTHRITIS; SECONDARY HEMOPHAGOCYTIC SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; COMPLICATION; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; YOUNG ADULT;

EID: 84955578015     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2016.01.002     Document Type: Article

References (32)

1. K. Lehmberg, and S. Ehl Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis Br J Haematol 160 2013 275 287
2. E. Sieni, V. Cetica, A. Piccin, and et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series PLoS One 7 2012 e44649
3. C.M. Rubin, B.A. Burke, R.W. McKenna, and et al. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 56 1985 524 530
4. A. Enders, B. Zieger, K. Schwarz, and et al. Lethal hemophagocytic lymphohistiocytosis in Hermanksy-Pudlak syndrome, type II Blood 108 2006 81 87
5. G. Menasche, E. Pastural, J. Feldmann, and et al. Mutations in RAB27A cause Griscelli syndrome associated haemophagocytic syndrome Nat Genet 25 2000 173 176
6. M. Arico, S. Imashuku, R. Clementi, and et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene Blood 97 2001 1131 1133
7. S. Rigaud, M.C. Fondaneche, N. Lambert, and et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome Nature 444 2006 110 114
8. K. Huck, O. Feyen, T. Niehues, and et al. Girls homozygous for an IL-2 inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation J Clin Invest 119 2009 1350 1358
9. N.G. Rouphael, N.J. Talati, C. Vaughan, and et al. Infections associated with haemophagocytic syndrome Lancet Infect Dis 7 2007 814 822
10. A. Stabile, B. Bertoni, V. Ansuini, and et al. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age Eur Rev Med Pharmacol Sci 10 2006 53 59
11. S. Sawhney, P. Woo, and K.J. Murray Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders Arch Dis Child 85 2001 421 426
12. O. Lambotte, M. Khellaf, H. Harmouche, and et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome Medicine (Baltimore) 85 2006 169 182
13. National Center for Health Statistics; Centers for Medicare and Medicaid Services. Conversion table of new ICD-9-CM codes. October 2011. 2013, Available at: http://www.cdc.gov/nchs/data/icd/ICD-9-CM-FY14-CNVTBL-Final.pdf. Accessed December 18, 2015.
14. J.I. Henter, A. Horne, M. Aricó, and et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 2007 124 131
15. A.M. Schram, F. Campigotto, A. Mullally, and et al. Marked hyperferritinemia does not predict for HLH in the adult population Blood 125 2015 1548 1552
16. S. Goel, J.M. Polski, and H. Imran Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis Ann Clin Lab Sci 42 2012 21 25
17. N. Takahashi, I. Miura, A. Chubachi, and et al. A clinicopathologic study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma Int J Hematol 74 2001 303 308
18. M.M. O'Brien, Y. Lee-Kim, T.I. George, and et al. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 50 2008 381 383
19. S. Nishiki, T. Yamane, M. Hino, and et al. B-precursor lymphoblastic leukemia/lymphoma manifested at onset as hemophagocytic syndrome Rinsho Byori 48 2000 975 979
20. M. Shabbir, J. Lucas, J. Lazarchick, and et al. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature Hematol Oncol 29 2011 100 106
21. M. Machaczka, J. Vaktnas, M. Klimkowska, and et al. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center Leuk Lymphoma 52 2011 613 619
22. S.A. Parikh, P. Kapoor, L. Letendre, and et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis Mayo Clin Proc 89 2014 484 492
23. N. Takahashi, A. Chubachi, M. Kume, and et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases Int J Hematol 74 2001 209 213
24. J. Li, Q. Wang, W. Zheng, and et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients Medicine (Baltimore) 93 2014 100 105
25. M. Arca, L. Fardet, L. Galicier, and et al. Prognostic factors of early death in a cohort of 162 adult hemophagocytic syndrome: impact of triggering disease and early treatment with etoposide Br J Haematol 168 2015 63 68
26. H.S. Park, D.Y. Kim, J.H. Lee, and et al. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors Ann Hematol 91 2012 897 904
27. C. Creput, L. Galicier, S. Buyse, and et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis Intensive Care Med 34 2008 1177 1187
28. H. Trottestam, E. Berglof, A. Horne, and et al. Risk factors for early death in children with hemophagocytic lymphohistiocytosis Acta Paediatr 101 2012 313 318
29. A. Horne, G. Janka, R. Maarten Egeler, and et al. Haematopoietic stem cell transplantation in haemophagocytic lymhohistiocytosis Br J Haematol 129 2005 622 630
30. H. Trottestam, A. Horne, M. Arico, and et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol Blood 118 2011 4577 4584
31. J.I. Henter, G. Elinder, O. Soder, and et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis Acta Paediatr Scand 80 1991 428 435
32. Y.T. Tseng, W.H. Sheng, B.H. Lin, and et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults J Microbiol Immunol Infect 44 2011 191 197